SPDR S&P Biotech ETF (NYSEARCA:XBI) Stock Position Reduced by Summit Trail Advisors LLC

Summit Trail Advisors LLC lessened its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 16.6% during the third quarter, HoldingsChannel reports. The institutional investor owned 12,548 shares of the exchange traded fund’s stock after selling 2,496 shares during the quarter. Summit Trail Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,240,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of XBI. Hartline Investment Corp raised its position in shares of SPDR S&P Biotech ETF by 2.0% during the 3rd quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock worth $544,000 after purchasing an additional 106 shares during the period. Intellectus Partners LLC raised its position in shares of SPDR S&P Biotech ETF by 1.0% during the 2nd quarter. Intellectus Partners LLC now owns 11,334 shares of the exchange traded fund’s stock worth $1,051,000 after purchasing an additional 113 shares during the period. Pacific Center for Financial Services raised its position in shares of SPDR S&P Biotech ETF by 2.8% during the 1st quarter. Pacific Center for Financial Services now owns 4,359 shares of the exchange traded fund’s stock worth $414,000 after purchasing an additional 118 shares during the period. Signature Estate & Investment Advisors LLC raised its position in shares of SPDR S&P Biotech ETF by 5.7% during the 3rd quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after purchasing an additional 125 shares during the period. Finally, Denver Wealth Management Inc. raised its position in shares of SPDR S&P Biotech ETF by 0.9% during the 3rd quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock worth $1,460,000 after purchasing an additional 127 shares during the period.

SPDR S&P Biotech ETF Price Performance

XBI opened at $96.24 on Monday. SPDR S&P Biotech ETF has a 12 month low of $71.99 and a 12 month high of $105.47. The stock has a market cap of $7.34 billion, a P/E ratio of 11.47 and a beta of 1.11. The stock’s 50 day moving average price is $98.44 and its 200 day moving average price is $96.32.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.